APA (7th ed.) Citation

A, M., AL, F., S, D. M., C, Z., F, P., F, M., . . . M, B. (2018). Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment. Bioorganic & medicinal chemistry letters, 28(21), 3454. https://doi.org/10.1016/j.bmcl.2018.09.024

Chicago Style (17th ed.) Citation

A, Molinari, et al. "Efficient Optimization of Pyrazolo[3,4-d]pyrimidines Derivatives as C-Src Kinase Inhibitors in Neuroblastoma Treatment." Bioorganic & Medicinal Chemistry Letters 28, no. 21 (2018): 3454. https://doi.org/10.1016/j.bmcl.2018.09.024.

MLA (9th ed.) Citation

A, Molinari, et al. "Efficient Optimization of Pyrazolo[3,4-d]pyrimidines Derivatives as C-Src Kinase Inhibitors in Neuroblastoma Treatment." Bioorganic & Medicinal Chemistry Letters, vol. 28, no. 21, 2018, p. 3454, https://doi.org/10.1016/j.bmcl.2018.09.024.